Spinal epidural hematoma following thrombolytic therapy for acute myocardial infarction;Hematoma epidural espinal tras terapia trombolitica en un infarto agudo de miocardio

Revista Espanola de Cardiologia

Volumn 50, Issue 6, 1997, Pages 448-450

  Zafra Sánchez, Javier ^a,b   De Mora Martín, Manuel ^a   Fernández Madero, Gabriel ^a   Hernández García, José María ^a   Barakat, Said ^a   Malpartida, Félix ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b NONE   (Spain)

Author keywords

acute myocardial infarction; spinal epidural hematoma; thrombolytic

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; HEPARIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EPIDURAL HEMATOMA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SYMPTOM;

EID: 0030952413     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(97)73247-0     Document Type: Article

References (8)

1. Lau J, Antman EM, Jiménez-Silva J, Kupelnick B, Masteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992; 327: 248-254.
2. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardio (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397-402.
3. ISIS-2 (Second International Study of Infart Survival) Collaborative Group. Randomised trial of intravenos streptokinase oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988; 2: 349-360.
4. Wilcox RG, Von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 1988; 336: 71-75.
5. LATE Study Group. late assesment of thrombolytic efficacy (LATE). Study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993; 342: 759-766.
6. ISIS-3 (Third International Study Of Infarct Survival) Collaborative Group. A randomised comparison of streptokinase vs tissue plasminogen activator vs anisteplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992; 339: 753-770.
7. Califf RM, Topol EJ, George BS, Boswick JM, Abbottsmith C, Sigmon KN et al. Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction. Lancet 1988; 2: 525-530.
8. Sawin PD, Traynelis VC, Follett KA. Spinal epidural hematoma following coronary thrombolysis with tissue plasminogen activator. J Neurosurg 1995; 83: 350-353.